HCG Injection Between LH Surge and Embryo Transfer
Updated: Jul 22
If you’ve spent any time in IVF groups, you may have seen people talk about a mysterious, slightly controversial technique:
“My clinic gave me an HCG booster after ovulation / before transfer.”
It’s not part of standard IVF protocols - but some doctors use it strategically for certain women.
Here’s what it actually means, why clinics sometimes use it, and who (if anyone) benefits.
First: What happens normally in a natural cycle?
When you ovulate naturally, your body releases:
LH surge → ovulation → corpus luteum produces progesterone AND natural HCG-like signals
That last part is the important one.
Your corpus luteum doesn’t produce actual HCG, but it produces biochemical signals that behave similarly enough to prepare the lining for implantation.
In a medicated cycle (or a natural cycle with luteal weakness), this signalling may be disrupted.
That’s where HCG injections come in.
What is “HCG between LH surge and transfer”?

This involves injecting a low dose of hCG after ovulation is confirmed, but before the embryo transfer, usually around one to three days after the LH surge, or one to three days before transfer, depending on clinic style.
The idea is that this mimics the early signals an embryo would give off before implantation. Embryos do genuinely talk to the endometrium before they implant, and hCG is one of the earliest signals.
Injecting it before transfer is a way of priming the lining, improving receptivity, boosting progesterone production in natural cycles, and supporting the corpus luteum.
Why would clinics use HCG after ovulation?
To improve implantation signalling: hCG is one of the earliest molecules an embryo secretes; giving it before transfer might create a more welcoming environment, essentially turning on the embryo has arrived light switch.
To support the corpus luteum: in natural or modified natural FETs, the corpus luteum is essential, and hCG strengthens it and boosts progesterone output.
To help women with weak ovulation or short luteal phases: some women ovulate but don't produce enough progesterone afterwards, and hCG can enhance their natural luteal function.
To compensate when the LH surge is unclear or borderline: if ovulation is confirmed but LH was weak, hCG adds stability.
Who might this benefit?
✔ Women doing natural or modified natural FETs
This is where the evidence is strongest(1).
✔ Women with short luteal phases
HCG can boost progesterone naturally.
✔ Women with borderline ovulation or silent ovulation
If LH fluctuates or ovulation is unclear, HCG stabilises luteal support.
✔ Women who previously had:
Biochemical pregnancies
Early implantation failures
Poor lining response in natural cycles
Unexplained failures with good embryos
✔ Women with low progesterone in early luteal phase
HCG can help the corpus luteum produce more.
Who probably won’t benefit?
✖ Women in a fully medicated FET
Your natural ovulation is already suppressed, so HCG isn’t useful (and some clinics avoid it).
✖ Women at risk of OHSS
HCG, even in tiny doses, can worsen OHSS risk.
✖ Women doing fresh transfers
Again - OHSS risk.
✖ Women with endometrial receptivity testing suggesting strict timing
Extra HCG may add unnecessary complexity.
What does the evidence say?
Studies are mixed but promising:

🌱 Some studies show(2)(3)(4):
Higher implantation rates
Better biochemical pregnancy rates
Improved luteal progesterone
Enhanced endometrial receptivity markers
🍂 Other studies show(5)(6)(7)
Little to no difference
Lab benefits, but not always clinical benefits
Inconsistent outcomes depending on timing
The general consensus:
👉 HCG before transfer may help a subset of women, especially in natural cycles
👉 Evidence is not strong enough for universal use
It’s very clinic-dependent and doctor-dependent.
Typical dosing
Most doctors use very small doses, such as 1,500 IU, 2,500 IU, or occasionally 5,000 IU (less common), given one to three days after the LH surge, or one to three days before transfer, or both, depending on protocol.
Summary
HCG between LH surge and transfer is a low-dose priming injection used in some natural or modified natural FETs
It aims to support the corpus luteum and improve endometrial receptivity
Evidence is mixed, but some women may benefit - especially those with luteal issues or past implantation failures
It is not standard or necessary for everyone
It should never be used in women at risk of OHSS
Overall: a gentle, low-risk, sometimes helpful technique.





Comments